Doximity, Inc.
DOCS Healthcare Health Information Services
Doximity, Inc.’s revenue for fiscal 2026 (year ended March 2026) was $644.9 million, up 13.1% from fiscal 2025.
- Revenue
- +3.57%
- EPS
- −42.4%
- Free cash flow
- +1.87%
Quarter to September 2026, against a year earlier
Follow DOCS
Alert me
Doximity, Inc. (DOCS) Total debt
Doximity, Inc.'s total debt at the end of fiscal 2023 was $16.0M, up 1,500.0% from $1.0M in fiscal 2022. At the end of the quarter to 30 September 2023 it was $15.0M. Doximity, Inc. ranks 29th of 42 Health Information Services companies by total debt.
Total debt, annual
Embed this chart
Annual newest first
| Period | Total debt | Change |
|---|---|---|
| FY2023 | $16.0M | 1,500.00% |
| FY2022 | $1.0M | 0.00% |
| FY2021 | $1.0M | (50.00%) |
| FY2020 | $2.0M | — |
Quarterly newest first
| Period | Total debt | Change |
|---|---|---|
| Sep 2023 | $15.0M | (6.25%) |
| Jun 2023 | $16.0M | 0.00% |
| Mar 2023 | $16.0M | 6.67% |
| Dec 2022 | $15.0M | (6.25%) |
| 9 more quarters | Free account |
Total debt against peers
| Company | Total debt |
|---|---|
| BTSG BrightSpring Health Services, Inc. compare | $2.2B |
| WAY Waystar Holding Corp. compare | $1.5B |
| TEM Tempus AI, Inc. compare | $1.4B |
| HQY HealthEquity, Inc. compare | $931.1M |
| HTFL Heartflow, Inc. compare | $182.4M |
| SDGR Schrodinger, Inc. compare | $129.0M |
| DOCS Doximity, Inc. | $15.0M |
| PRVA Privia Health Group, Inc. compare | $5.8M |
| HNGE Hinge Health Inc. compare | — |
What Total debt is
Total Debt tells an investor how much a company has borrowed in all, whether the money is due within a year or later.
Long Term Debt (Total) + Current Part of Debt
More on DOCS
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement